{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:01:23Z","timestamp":1793826083979,"version":"4.6.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2016R1E1A1A01941212"],"award-info":[{"award-number":["2016R1E1A1A01941212"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017M3C7A1028949"],"award-info":[{"award-number":["2017M3C7A1028949"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI14C1913"],"award-info":[{"award-number":["HI14C1913"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cilostazol, a phosphodiesterase 3 inhibitor, reduces the amyloid-beta (A\u03b2) burden in mouse models of Alzheimer disease by as yet unidentified mechanisms. In the present study, we examined the possibility that cilostazol ameliorates lysosomal dysfunction. Astrocytes treated with bafilomycin A1 (BafA1) exhibited markedly reduced DND-189 and acridine orange (AO) fluorescence, indicating reduced lysosomal acidity. In both cases, BafA1-induced alkalization was reversed by addition of cilostazol, dibutyryl cAMP or forskolin. All three agents significantly increased free zinc levels in lysosomes, and addition of the zinc chelator TPEN abrogated lysosomal reacidification. These treatments did not raise free zinc levels or reverse BafA1-mediated lysosomal alkalization in metallothionein 3 (Mt3)-null astrocytes, indicating that the increases in zinc in astrocytes were derived mainly from Mt3. Lastly, in FITC-A\u03b2-treated astrocytes, cilostazol reversed lysosomal alkalization, increased cathepsin D activity, and reduced A\u03b2 accumulation in astrocytes. Cilostazol also reduced mHtt aggregate formation in GFP-mHttQ74\u2013expressing astrocytes. Collectively, our results present the novel finding that cAMP\/PKA can overcome the v-ATPase blocking effect of BafA1 in a zinc- and Mt3-dependent manner.<\/jats:p>","DOI":"10.1038\/s41598-020-66292-3","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T10:05:16Z","timestamp":1591610716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Cilostazol restores autophagy flux in bafilomycin A1-treated, cultured cortical astrocytes through lysosomal reacidification: roles of PKA, zinc and metallothionein 3"],"prefix":"10.1038","volume":"10","author":[{"given":"Ha Na","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Ra","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0264-4531","authenticated-orcid":false,"given":"Hyunjin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Young","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,8]]},"reference":[{"key":"66292_CR1","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1038\/nm1066","volume":"10","author":"CA Ross","year":"2004","unstructured":"Ross, C. A. & Poirier, M. A. Protein aggregation and neurodegenerative disease. Nat Med. 10, S10\u2013S17 (2004).","journal-title":"Nat Med."},{"key":"66292_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40035-017-0077-5","volume":"6","author":"P Sweeney","year":"2017","unstructured":"Sweeney, P. et al. Protein misfolding in neurodegenerative diseases: implications and strategies. Transl Neurodegener. 6, 6 (2017).","journal-title":"Transl Neurodegener."},{"key":"66292_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3389\/fnins.2018.00255","volume":"12","author":"N Fujikake","year":"2018","unstructured":"Fujikake, N., Shin, M. & Shimizu, S. Association Between Autophagy and Neurodegenerative Diseases. Front Neurosci. 12, 255 (2018).","journal-title":"Front Neurosci."},{"key":"66292_CR4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2217\/14796708.3.3.309","volume":"3","author":"SJ Cherra","year":"2008","unstructured":"Cherra, S. J. & Chu, C. T. Autophagy in neuroprotection and neurodegeneration: A question of balance. Future Neurol. 3, 309\u2013323 (2008).","journal-title":"Future Neurol."},{"key":"66292_CR5","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.neuron.2017.01.022","volume":"93","author":"FM Menzies","year":"2017","unstructured":"Menzies, F. M. et al. Autophagy and neurodegeneration: Pathogenic mechanisms and therapeutic opportunities. Neuron. 93, 1015\u20131034 (2017).","journal-title":"Neuron."},{"key":"66292_CR6","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1084\/jem.20150956","volume":"212","author":"DC Rubinsztein","year":"2012","unstructured":"Rubinsztein, D. C., Bento, C. F. & Deretic, V. Therapeutic targeting of autophagy in neurodegenerative and infectious diseases. J Exp Med. 212, 979\u201390 (2012).","journal-title":"J Exp Med."},{"key":"66292_CR7","first-page":"2190","volume":"118","author":"F Pickford","year":"2008","unstructured":"Pickford, F. et al. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest. 118, 2190\u20139 (2008).","journal-title":"J Clin Invest."},{"key":"66292_CR8","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1001\/archneurol.2010.258","volume":"67","author":"PA Jaeger","year":"2010","unstructured":"Jaeger, P. A. & Wyss-Coray, T. Beclin 1 complex in autophagy and Alzheimer disease. Arch Neurol. 67, 1181\u20134 (2010).","journal-title":"Arch Neurol."},{"issue":"6","key":"66292_CR9","doi-asserted-by":"publisher","first-page":"e11102","DOI":"10.1371\/journal.pone.0011102","volume":"5","author":"PA Jaeger","year":"2010","unstructured":"Jaeger, P. A. et al. Regulation of amyloid precursor protein processing by the Beclin 1 complex. PLoS One. 5(6), e11102 (2010).","journal-title":"PLoS One."},{"key":"66292_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/alzrt217","volume":"5","author":"ME Orr","year":"2013","unstructured":"Orr, M. E. & Oddo, S. Autophagic\/lysosomal dysfunction in Alzheimer\u2019s disease. Alzheimers Res Ther. 5, 53 (2013).","journal-title":"Alzheimers Res Ther."},{"key":"66292_CR11","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1242\/jcs.196352","volume":"130","author":"S Nakamura","year":"2017","unstructured":"Nakamura, S. & Yoshimori, T. New insights into autophagosome\u2013lysosome fusion. J Cell Sci. 130, 1209\u20131216 (2017).","journal-title":"J Cell Sci."},{"key":"66292_CR12","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","volume":"14","author":"M Mauthe","year":"2018","unstructured":"Mauthe, M. et al. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy. 14, 1435\u20131455 (2018).","journal-title":"Autophagy."},{"key":"66292_CR13","doi-asserted-by":"publisher","first-page":"35769","DOI":"10.1074\/jbc.M113.511212","volume":"288","author":"M Li","year":"2013","unstructured":"Li, M. et al. Suppression of lysosome function induces autophagy via a feedback down-regulation of MTOR complex 1 (MTORC1) activity. J Biol Chem. 288, 35769\u201335780 (2013).","journal-title":"J Biol Chem."},{"key":"66292_CR14","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.cell.2010.05.008","volume":"141","author":"JH Lee","year":"2010","unstructured":"Lee, J. H. et al. Lysosomal Proteolysis and Autophagy Require Presenilin 1 and Are Disrupted by Alzheimer-Related PS1 Mutations. Cell 141, 1146\u201358 (2010).","journal-title":"Cell"},{"key":"66292_CR15","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1042\/BST20130201","volume":"41","author":"M McBrayer","year":"2013","unstructured":"McBrayer, M. & Nixon, R. A. Lysosome and calcium dysregulation in Alzheimer\u2019s disease: partners in crime. Biochem Soc Trans. 41, 1495\u20131502 (2013).","journal-title":"Biochem Soc Trans."},{"key":"66292_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0811-3","volume":"17","author":"S Pamarthy","year":"2018","unstructured":"Pamarthy, S., Kulshrestha, A., Katara, G. K. & Beaman, K. D. The curious case of vacuolar ATPase: regulation of signaling pathways. Mol Cancer. 17, 41 (2018).","journal-title":"Mol Cancer."},{"key":"66292_CR17","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.tins.2006.07.003","volume":"29","author":"RA Nixon","year":"2006","unstructured":"Nixon, R. A. Autophagy in neurodegenerative disease: friend, foe or turncoat? Trends Neurosci. 29, 528\u201335 (2006).","journal-title":"Trends Neurosci."},{"key":"66292_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.brainres.2016.03.047","volume":"1649","author":"S Maday","year":"2016","unstructured":"Maday, S. Mechanisms of neuronal homeostasis: autophagy in the axon. Brain Res. 1649, 143\u2013150 (2016).","journal-title":"Brain Res."},{"key":"66292_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00401-011-0896-x","volume":"23","author":"R Sanchez-Varo","year":"2012","unstructured":"Sanchez-Varo, R. et al. Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer\u2019s mice hippocampus. Acta Neuropathol. 23, 53\u201370 (2012).","journal-title":"Acta Neuropathol."},{"key":"66292_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/jnen\/64.2.113","volume":"64","author":"RA Nixon","year":"2005","unstructured":"Nixon, R. A. et al. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol. 64, 113\u2013122 (2005).","journal-title":"J Neuropathol Exp Neurol."},{"key":"66292_CR21","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.bbamcr.2009.01.016","volume":"1793","author":"Z Yue","year":"2009","unstructured":"Yue, Z., Friedman, L., Komatsu, M. & Tanaka, K. The cellular pathways of neuronal autophagy and their implication in neurodegenerative diseases. Biochim Biophys Acta. 1793, 1496\u20131507 (2009).","journal-title":"Biochim Biophys Acta."},{"key":"66292_CR22","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1083\/jcb.201611113","volume":"216","author":"V Vijayan","year":"2017","unstructured":"Vijayan, V. & Verstreken, P. Autophagy in the presynaptic compartment in health and disease. J Cell Biol. 216, 1895\u20131906 (2017).","journal-title":"J Cell Biol."},{"key":"66292_CR23","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1096\/fj.201700359","volume":"31","author":"RA Nixon","year":"2017","unstructured":"Nixon, R. A. Amyloid precursor protein and endosomal\u2013lysosomal dysfunction in Alzheimer\u2019s disease: inseparable partners in a multifactorial disease. FASEB J. 31, 2729\u20132743 (2017).","journal-title":"FASEB J."},{"key":"66292_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.arr.2016.05.004","volume":"32","author":"DJ Colacurcio","year":"2016","unstructured":"Colacurcio, D. J. & Nixon, R. A. Disorders of lysosomal acidification-The emerging role of v-ATPase in aging and neurodegenerative disease. Ageing Res Rev. 32, 75\u201388 (2016).","journal-title":"Ageing Res Rev."},{"key":"66292_CR25","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.bbabio.2015.06.010","volume":"1847","author":"GH Sun-Wada","year":"2015","unstructured":"Sun-Wada, G. H. & Wada, Y. Role of vacuolar-type proton ATPase in signal transduction. Biochim Biophys Acta. 1847, 1166\u201372 (2015).","journal-title":"Biochim Biophys Acta."},{"key":"66292_CR26","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.bbabio.2016.02.010","volume":"1857","author":"C McGuire","year":"2016","unstructured":"McGuire, C., Cotter, K., Stransky, L. & Forgac, M. Regulation of V-ATPase Assembly and Function of V-ATPases in Tumor Cell Invasiveness. Biochim Biophys Acta. 1857, 1213\u20131218 (2016).","journal-title":"Biochim Biophys Acta."},{"key":"66292_CR27","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.1073\/pnas.0600011103","volume":"103","author":"P Dames","year":"2006","unstructured":"Dames, P. et al. cAMP regulates plasma membrane vacuolar-type H+-ATPase assembly and activity in blowfly salivary glands. Proc Natl Acad Sci USA 103, 3926\u20133931 (2006).","journal-title":"Proc Natl Acad Sci USA"},{"key":"66292_CR28","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.1242\/jcs.158550","volume":"127","author":"ME Maxson","year":"2014","unstructured":"Maxson, M. E. & Grinstein, S. The vacuolar-type H+-ATPase at a glance - more than a proton pump. J Cell Sci. 127, 4987\u20134993 (2014).","journal-title":"J Cell Sci."},{"key":"66292_CR29","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.celrep.2015.07.050","volume":"12","author":"JH Lee","year":"2015","unstructured":"Lee, J. H. et al. Presenilin 1 Maintains Lysosomal Ca(2+) Homeostasis via TRPML1 by Regulating vATPase-Mediated Lysosome Acidification. Cell Rep. 12, 1430\u20131444 (2015).","journal-title":"Cell Rep."},{"key":"66292_CR30","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ceca.2017.06.006","volume":"69","author":"S Di Paola","year":"2018","unstructured":"Di Paola, S., Scotto-Rosato, A. & Medina, D. L. TRPML1: The Ca(2+) retaker of the lysosome. Cell Calcium. 69, 112\u2013121 (2018).","journal-title":"Cell Calcium."},{"key":"66292_CR31","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1016\/j.neurobiolaging.2015.09.006","volume":"36","author":"BR Seo","year":"2015","unstructured":"Seo, B. R., Lee, S. J., Cho, K. S., Yoon, Y. H. & Koh, J. Y. The zinc ionophore clioquinol reverses autophagy arrest in chloroquine-treated ARPE-19 cells and in APP\/mutant presenilin-1-transfected Chinese hamster ovary cells. Neurobiol Aging. 36, 3228\u201338 (2015).","journal-title":"Neurobiol Aging."},{"key":"66292_CR32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1527-3466.2001.tb00076.x","volume":"19","author":"Y Liu","year":"2001","unstructured":"Liu, Y., Shakur, Y. & Yoshitake, M. & Kambayashi Ji J. Cilostazol (pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake. Cardiovasc Drug Rev. 19, 369\u201386 (2001).","journal-title":"Cardiovasc Drug Rev."},{"key":"66292_CR33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0014-2999(96)00551-1","volume":"314","author":"U Ikeda","year":"1996","unstructured":"Ikeda, U., Ikeda, M., Kano, S., Kanbe, T. & Shimada, K. Effect of cilostazol, a cAMP phosphodiesterase inhibitor, on nitric oxide production by vascular smooth muscle cells. Eur J Pharmacol. 314, 197\u2013202 (1996).","journal-title":"Eur J Pharmacol."},{"key":"66292_CR34","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1161\/ATVBAHA.111.230987","volume":"31","author":"WJ Chen","year":"2011","unstructured":"Chen, W. J., Chen, Y. H., Lin, K. H., Ting, C. H. & Yeh, Y. H. Cilostazol promotes vascular smooth muscles cell differentiation through the cAMP response element-binding protein-dependent pathway. Arterioscler Thromb Vasc Biol. 31, 2106\u20132113 (2011).","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"66292_CR35","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/01.CIR.98.7.678","volume":"98","author":"DL Dawson","year":"1998","unstructured":"Dawson, D. L., Cutler, B. S., Meissner, M. H. & Strandness, D. E. Jr. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. Circulation. 98, 678\u2013686 (1998).","journal-title":"Circulation."},{"key":"66292_CR36","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/00005344-199910000-00004","volume":"34","author":"J Cone","year":"1999","unstructured":"Cone, J. et al. Comparison of the effects of cilostazol and milrinone on intracellular cAMP levels and cellular function in platelets and cardiac cells. J Cardiovasc Pharmacol. 34, 497\u2013504 (1999).","journal-title":"J Cardiovasc Pharmacol."},{"key":"66292_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jphs.2016.04.023","volume":"131","author":"T Takagi","year":"2016","unstructured":"Takagi, T. & Hara, H. Protective effects of cilostazol against hemorrhagic stroke: Current and future perspectives. J Pharmacol Sci. 131, 155\u201361 (2016).","journal-title":"J Pharmacol Sci."},{"key":"66292_CR38","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1080\/14656566.2018.1515199","volume":"19","author":"K Noma","year":"2018","unstructured":"Noma, K. & Higashi, Y. Cilostazol for treatment of cerebral infarction. Expert Opin Pharmacother. 19, 1719\u20131726 (2018).","journal-title":"Expert Opin Pharmacother."},{"key":"66292_CR39","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1161\/STROKEAHA.110.609834","volume":"42","author":"N Oyama","year":"2011","unstructured":"Oyama, N. et al. Cilostazol, not aspirin, reduces ischemic brain injury via endothelial protection in spontaneously hypertensive rats. Stroke. 42, 2571\u20137 (2011).","journal-title":"Stroke."},{"key":"66292_CR40","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.neulet.2009.01.039","volume":"452","author":"Y Nonaka","year":"2009","unstructured":"Nonaka, Y. et al. Cilostazol protects against hemorrhagic transformation in mice transient focal cerebral ischemia-induced brain damage. Neurosci Lett. 452, 156\u2013161 (2009).","journal-title":"Neurosci Lett."},{"key":"66292_CR41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2459\/JCM.0b013e3283439746","volume":"12","author":"N Kanlop","year":"2011","unstructured":"Kanlop, N., Chattipakorn, S. & Chattipakorn, N. Effects of cilostazol in the heart. J Cardiovasc Med. 12, 88\u201395 (2011).","journal-title":"J Cardiovasc Med."},{"key":"66292_CR42","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1161\/01.STR.0000221783.08037.a9","volume":"37","author":"T Watanabe","year":"2006","unstructured":"Watanabe, T. et al. Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion. Stroke. 37, 1539\u201345 (2006).","journal-title":"Stroke."},{"key":"66292_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04082-0","volume":"7","author":"A Kitamura","year":"2017","unstructured":"Kitamura, A. et al. Long-term cilostazol treatment reduces gliovascular damage and memory impairment in a mouse model of chronic cerebral hypoperfusion. Sci Rep. 7, 4299 (2017).","journal-title":"Sci Rep."},{"key":"66292_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1527-3458.2008.00042.x","volume":"14","author":"JH Lee","year":"2008","unstructured":"Lee, J. H. et al. Protective effects of cilostazol against transient focal cerebral ischemia and chronic cerebral hypoperfusion injury. CNS Neurosci Ther. 14, 143\u2013152 (2008).","journal-title":"CNS Neurosci Ther."},{"key":"66292_CR45","doi-asserted-by":"publisher","first-page":"e0160620","DOI":"10.1371\/journal.pone.0160620","volume":"11","author":"SY Park","year":"2016","unstructured":"Park, S. Y. et al. Cilostazol Modulates Autophagic Degradation of \u03b2-Amyloid Peptide via SIRT1-Coupled LKB1\/AMPK\u03b1 Signaling in Neuronal Cells. PLoS One. 11, e0160620 (2016).","journal-title":"PLoS One."},{"key":"66292_CR46","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2011.04.068","volume":"408","author":"SH Park","year":"2011","unstructured":"Park, S. H. et al. Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid \u03b2-induced cognitive deficits associated with decreased amyloid \u03b2 accumulation. Biochem Biophys Res Commun. 408, 602\u20138 (2011).","journal-title":"Biochem Biophys Res Commun."},{"key":"66292_CR47","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1111\/j.1476-5381.2010.01014.x","volume":"161","author":"M Hiramatsu","year":"2010","unstructured":"Hiramatsu, M., Takiguchi, O., Nishiyama, A. & Mori, H. Cilostazol prevents amyloid \u03b2 peptide25-35-induced memory impairment and oxidative stress in mice. Br J Pharmacol. 161, 1899\u20131912 (2010).","journal-title":"Br J Pharmacol."},{"key":"66292_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neuroscience.2014.01.001","volume":"263","author":"EE Coffey","year":"2014","unstructured":"Coffey, E. E., Beckel, J. M., Laties, A. M. & Mitchell, C. H. Lysosomal alkalization and dysfunction in human fibroblasts with the Alzheimer\u2019s disease-linked presenilin 1 A246E mutation can be reversed with cAMP. Neuroscience. 263, 111\u201324 (2014).","journal-title":"Neuroscience."},{"key":"66292_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-019-0439-2","volume":"12","author":"JY Koh","year":"2019","unstructured":"Koh, J. Y., Kim, H. N., Hwang, J. J., Kim, Y. H. & Park, S. E. Lysosomal dysfunction in proteinopathic neurodegenerative disorders: possible therapeutic roles of cAMP and zinc. Mol Brain. 12, 18 (2019).","journal-title":"Mol Brain."},{"key":"66292_CR50","doi-asserted-by":"publisher","first-page":"e17029","DOI":"10.1038\/sigtrans.2017.29","volume":"2","author":"E Bafaro","year":"2017","unstructured":"Bafaro, E., Liu, Y., Xu, Y. & Dempski, R. E. The emerging role of zinc transporters in cellular homeostasis and cancer. Signal Transduct Target Ther. 2, e17029 (2017).","journal-title":"Signal Transduct Target Ther."},{"key":"66292_CR51","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jnutbio.2018.10.008","volume":"64","author":"J Ollig","year":"2019","unstructured":"Ollig, J., Kloubert, V., Taylor, K. M. & Rink, L. B cell activation and proliferation increase intracellular zinc levels. J Nutr Biochem. 64, 72\u20139 (2019).","journal-title":"J Nutr Biochem."},{"key":"66292_CR52","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1039\/C8MT00248G","volume":"10","author":"T Aratake","year":"2018","unstructured":"Aratake, T. et al. The inhibitory role of intracellular free zinc in the regulation of Arg-1 expression in interleukin-4-induced activation of M2 microglia. Metallomics. 10, 1501\u20139 (2018).","journal-title":"Metallomics."},{"key":"66292_CR53","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/glia.20998","volume":"58","author":"SJ Lee","year":"2010","unstructured":"Lee, S. J., Park, M. H., Kim, H. J. & Koh, J. Y. Metallothionein-3 regulates lysosomal function in cultured astrocytes under both normal and oxidative conditions. Glia. 58, 1186\u20131196 (2010).","journal-title":"Glia."},{"key":"66292_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/1756-6606-3-30","volume":"3","author":"SJ Lee","year":"2010","unstructured":"Lee, S. J. & Koh, J. Y. Roles of zinc and metallothionein-3 in oxidative stress-induced lysosomal dysfunction, cell death, and autophagy in neurons and astrocytes. Mol Brain. 3, 30 (2010).","journal-title":"Mol Brain."},{"key":"66292_CR55","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/nrd2272","volume":"6","author":"DC Rubinsztein","year":"2007","unstructured":"Rubinsztein, D. C., Gestwicki, J. E., Murphy, L. O. & Klionsky, D. J. Potential therapeutic applications of autophagy. Nat Rev Drug Discov. 6, 304\u201312 (2007).","journal-title":"Nat Rev Drug Discov."},{"key":"66292_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2014.117","volume":"47","author":"A Ciechanover","year":"2015","unstructured":"Ciechanover, A. & Kwon, Y. T. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med. 47, e147 (2015).","journal-title":"Exp Mol Med."},{"key":"66292_CR57","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1750-1326-5-14","volume":"5","author":"L Schneider","year":"2010","unstructured":"Schneider, L. & Zhang, J. Lysosomal function in macromolecular homeostasis and bioenergetics in Parkinson\u2019s disease. Mol Neurodegener. 5, 14 (2010).","journal-title":"Mol Neurodegener."},{"key":"66292_CR58","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40035-015-0041-1","volume":"4","author":"YB Hu","year":"2015","unstructured":"Hu, Y. B., Dammer, E. B., Ren, R. J. & Wang, G. The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration. Transl Neurodegener. 4, 18 (2015).","journal-title":"Transl Neurodegener."},{"key":"66292_CR59","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/jmcb\/mjt022","volume":"5","author":"H Appelqvist","year":"2013","unstructured":"Appelqvist, H., W\u00e4ster, P., K\u00e5gedal, K. & \u00d6llinger, K. The lysosome: from waste bag to potential therapeutic target. J Mol Cell Biol. 5, 214\u2013226 (2013).","journal-title":"J Mol Cell Biol."},{"key":"66292_CR60","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fcell.2017.00110","volume":"5","author":"N Plotegher","year":"2017","unstructured":"Plotegher, N. & Duchen, M. R. Crosstalk between Lysosomes and Mitochondria in Parkinson\u2019s Disease. Front Cell Dev Biol. 5, 110 (2017).","journal-title":"Front Cell Dev Biol."},{"key":"66292_CR61","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.neurobiolaging.2014.10.037","volume":"36","author":"M Gan","year":"2015","unstructured":"Gan, M., Moussaud, S., Jiang, P. & McLean, P. J. Extracellular ATP induces intracellular alpha-synuclein accumulation via P2X1 receptor-mediated lysosomal dysfunction. Neurobiol Aging. 36, 1209\u20131220 (2015).","journal-title":"Neurobiol Aging."},{"key":"66292_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/srep21658","volume":"6","author":"SY Shim","year":"2016","unstructured":"Shim, S. Y., Karri, S., Law, S., Schatzl, H. M. & Gilch, S. Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cells. Sci Rep. 6, 21658 (2016).","journal-title":"Sci Rep."},{"key":"66292_CR63","doi-asserted-by":"publisher","first-page":"e1006882","DOI":"10.1371\/journal.pcbi.1006882","volume":"15","author":"Y Golan","year":"2019","unstructured":"Golan, Y., Alhadeff, R., Warshel, A. & Assaraf, Y. G. ZnT2 is an electroneutral proton-coupled vesicular antiporter displaying an apparent stoichiometry of two protons per zinc ion. PLoS Comput Biol. 15, e1006882 (2019).","journal-title":"PLoS Comput Biol."},{"key":"66292_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0171-8","volume":"9","author":"MS Shim","year":"2018","unstructured":"Shim, M. S. et al. Elevated intracellular cAMP exacerbates vulnerability to oxidative stress in optic nerve head astrocytes. Cell Death Dis. 9, 285 (2018).","journal-title":"Cell Death Dis."},{"key":"66292_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/srep28548","volume":"6","author":"MH Yoo","year":"2016","unstructured":"Yoo, M. H., Kim, T. Y., Yoon, Y. H. & Koh, J. Y. Autism phenotypes in ZnT3 null mice: Involvement of zinc dyshomeostasis, MMP-9 activation and BDNF upregulation. Sci rep. 6, 28548 (2016).","journal-title":"Sci rep."},{"key":"66292_CR66","doi-asserted-by":"publisher","first-page":"11995","DOI":"10.1074\/jbc.M403172200","volume":"280","author":"JJ Hwang","year":"2005","unstructured":"Hwang, J. J., Park, M. H., Choi, S. Y. & Koh, J. Y. Activation of the Trk signaling pathway by extracellular zinc. Role of metalloproteinases. J Biol Chem 280, 11995\u201312001 (2005).","journal-title":"J Biol Chem"},{"key":"66292_CR67","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.neuint.2011.11.015","volume":"60","author":"HN Kim","year":"2012","unstructured":"Kim, H. N., Lee, S. J. & Koh, J. Y. The neurosteroids, allopregnanolone and progesterone, induce autophagy in cultured astrocytes. Neurochem Int 60, 125\u201333 (2012).","journal-title":"Neurochem Int"},{"key":"66292_CR68","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.taap.2016.12.004","volume":"315","author":"JA Choi","year":"2017","unstructured":"Choi, J. A. et al. The anti-ALS drug riluzole attenuates pericyte loss in the diabetic retinopathy of streptozotocin-treated mice. Toxicol Appl Pharmacol 315, 80\u201389 (2017).","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66292-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66292-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66292-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T11:39:16Z","timestamp":1670326756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66292-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,8]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["66292"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-66292-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,8]]},"assertion":[{"value":"22 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9175"}}